Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HPV-Negative Adenocarcinomas of the Uterine Cervix: From Molecular Characterization to Clinical Implications. | Int J Mol Sci | 2022 | 36499345 | PubTator, text mining | PubMed |
| [The diagnostic value of CCNB3 and BCOR expression in BCOR-CCNB3 sarcoma]. | Zhonghua Bing Li Xue Za Zhi | 2022 | 36480832 | PubTator, text mining | PubMed |
| Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemia. | EJHaem | 2022 | 36467830 | PubTator, text mining | PubMed |
| Clinical significance of the increased expression of the WT1 gene in peripheral blood of patients with acquired aplastic anemia. | EJHaem | 2022 | 36467821 | PubTator, text mining | PubMed |
| High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project. | Sci Rep | 2022 | 36446856 | PubTator, text mining | PubMed |
| Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia. | Proc Natl Acad Sci U S A | 2022 | 36442087 | PubTator, text mining | PubMed |
| Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells. | Sci Rep | 2022 | 36434031 | PubTator, text mining | PubMed |
| Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic Arsenal. | Int J Mol Sci | 2022 | 36430703 | PubTator, text mining | PubMed |
| Transcriptome Alterations Caused by Social Defeat Stress of Various Durations in Mice and Its Relevance to Depression and Posttraumatic Stress Disorder in Humans: A Meta-Analysis. | Int J Mol Sci | 2022 | 36430271 | PubTator, text mining | PubMed |
IDH Mutations Are Potentially the Intrinsic Genetic Link among the Multiple Neoplastic Lesions in Ollier Disease and Maffucci Syndrome: A Clinicopathologic Analysis from a Single Institute in Shanghai, China. | Diagnostics (Basel) | 2022 | 36428825 | PubTator, text mining | PubMed |
| Plasticity in Classical Hodgkin Composite Lymphomas: A Systematic Review. | Cancers (Basel) | 2022 | 36428786 | PubTator, text mining | PubMed |
| The Growing Role of the BH3 Mimetic Drug Venetoclax in the Therapy of Acute Myeloid Leukemia. | Mediterr J Hematol Infect Dis | 2022 | 36425147 | PubTator, text mining | PubMed |
| What's new in soft tissue and bone pathology 2022-updates from the WHO classification 5th edition. | J Pathol Transl Med | 2022 | 36413981 | PubTator, text mining | PubMed |
| BCL6-SPECC1L: A Novel Fusion Gene in Nasopharyngeal Carcinoma. | Technol Cancer Res Treat | 2022 | 36412101 | PubTator, text mining | PubMed |
| Acquired and hereditary bone marrow failure: A mitochondrial perspective. | Front Oncol | 2022 | 36408191 | PubTator, text mining | PubMed |
| Retinoblastoma: Review and new insights. | Front Oncol | 2022 | 36408154 | PubTator, text mining | PubMed |
| Identification of six hub genes in mantle cell lymphoma patients with BTKi resistance. | Ann Transl Med | 2022 | 36388812 | PubTator, text mining | PubMed |
| Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia. | Front Oncol | 2022 | 36387170 | PubTator, text mining | PubMed |
| Increased slow dynamics defines ligandability of BTB domains. | Nat Commun | 2022 | 36384931 | PubTator, text mining | PubMed |
| A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib. | Clin Case Rep | 2022 | 36381034 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=42